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Background:  Surgical repair of Tetralogy of Fallot (TOF) can result in significant pulmonary regurgitation (PR) that leads to right ventricular (RV) 
enlargement, arrhythmias, and clinical symptoms. While pulmonary valve replacement (PVR) is an established treatment for PR, the optimal timing 
for surgery and the effect on patient clinical status is not clearly defined.
Methods:  We examined a cohort of 43 TOF patients from our Adult Congenital Heart Center who underwent PVR for significant PR. We compared 
patients who were operated with associated symptoms (n=23), including dyspnea, functional decline, heart failure, or sustained arrhythmias, to 
asymptomatic patients (n=20) who received PVR solely on the basis of RV dilatation or dysfunction. Changes in health status were assessed using 
NYHA functional class and the RAND-36 quality of life survey.
Results:  At least moderate PR was present in 42 (98%) patients. Symptomatic patients were older (44 ± 9 v. 36 ± 8, p = 0.008) with a higher 
frequency of supraventricular arrhythmias (61% v. 20%, p = 0.007) and tricuspid regurgitation (39% v. 9%, p = 0.03) than asymptomatic patients. 
Both groups had comparable RV end diastolic volume indices (185 ± 21 v. 201 ± 72 cc/m2, p = 0.56) and RV ejection fraction (44% ± 11 v. 
40% ± 9, p = 0.33) by MRI. PVR was performed achieving ≤ 1+ PR in 42 (98%) patients with durable results at 3 years of follow-up by echo. In the 
symptomatic group, 18 (78%) had improvement in NYHA class or remained in NYHA class I. The asymptomatic group remained free of heart failure 
at long term follow-up. Based upon the RAND-36 health survey, 19 (83%) symptomatic patients noted mild to significant improvement in quality of 
life after PVR compared to 13 (65%) asymptomatic patients. Categories of improvement for both groups included physical limitations (55 ± 74 v. 12 
± 24, p = 0.003) and general health (27 ± 17 v. 16 ± 18, p = 0.03). The symptomatic group also reported improvement in all other tested domains 
of quality of life.
Conclusions:  PVR improves quality of life in adult TOF patients with significant PR and RV dilation. The results of the RAND-36 survey reinforce the 
need to rely on quantitative measures of RV size and function even in the absence of preoperative symptoms.
